Year-over-year, this metric declined by 100.0%, from $95.75M to $0.00. Over 3 years (FY 2021 to FY 2024), Consumer — D&A shows a downward trend with a -100.0% CAGR.
Higher levels relative to revenue may indicate an asset-heavy business model or recent significant capital investments that are now being expensed.
The non-cash expense allocated to the Consumer Health segment to account for the gradual wear and tear of physical asset...
Standard across all industries; comparable to segment-level D&A reported by any company with distinct operating segments.
jnj_segment_consumer_health_depreciation_and_amortization| FY'21 | FY'22 | FY'23 | FY'24 | |
|---|---|---|---|---|
| Value | $785.00M | $759.00M | $383.00M | $0.00 |
| YoY Change | — | -3.3% | -49.5% | -100.0% |
We use cookies for analytics. See our Privacy and Cookie Policy.